651 related articles for article (PubMed ID: 18366303)
1. Gene expression profiling of non-small-cell lung cancer.
Lacroix L; Commo F; Soria JC
Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
[TBL] [Abstract][Full Text] [Related]
3. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of non-small cell lung cancer: of what value in clinical practice?
Newnham GM; Thomas DM; McLachlan SA; Wright G; Conron M
Heart Lung Circ; 2008 Dec; 17(6):451-62. PubMed ID: 18676201
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
Dacic S
Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
[TBL] [Abstract][Full Text] [Related]
6. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
[TBL] [Abstract][Full Text] [Related]
7. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer.
Taniwaki M; Daigo Y; Ishikawa N; Takano A; Tsunoda T; Yasui W; Inai K; Kohno N; Nakamura Y
Int J Oncol; 2006 Sep; 29(3):567-75. PubMed ID: 16865272
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review.
Singhal S; Vachani A; Antin-Ozerkis D; Kaiser LR; Albelda SM
Clin Cancer Res; 2005 Jun; 11(11):3974-86. PubMed ID: 15930332
[TBL] [Abstract][Full Text] [Related]
11. A training-testing approach to the molecular classification of resected non-small cell lung cancer.
Yamagata N; Shyr Y; Yanagisawa K; Edgerton M; Dang TP; Gonzalez A; Nadaf S; Larsen P; Roberts JR; Nesbitt JC; Jensen R; Levy S; Moore JH; Minna JD; Carbone DP
Clin Cancer Res; 2003 Oct; 9(13):4695-704. PubMed ID: 14581339
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling and lung cancer development.
Borczuk AC; Powell CA
Proc Am Thorac Soc; 2007 Jan; 4(1):127-32. PubMed ID: 17202302
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic and molecular aspects of lung cancer.
Panani AD; Roussos C
Cancer Lett; 2006 Jul; 239(1):1-9. PubMed ID: 16112428
[TBL] [Abstract][Full Text] [Related]
14. Re: Gene expression-based prognostic signatures in lung cancer: ready for clinical use?
Boutros PC; Pintilie M; John T; Starmans MH; Der SD; Shepherd FA; Tsao MS; Jurisica I
J Natl Cancer Inst; 2010 Nov; 102(21):1677-8; author reply 1678-9. PubMed ID: 20921041
[No Abstract] [Full Text] [Related]
15. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes.
Kuner R; Muley T; Meister M; Ruschhaupt M; Buness A; Xu EC; Schnabel P; Warth A; Poustka A; Sültmann H; Hoffmann H
Lung Cancer; 2009 Jan; 63(1):32-8. PubMed ID: 18486272
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of using low-volume tissue samples for gene expression profiling of advanced non-small cell lung cancers.
Lim EH; Aggarwal A; Agasthian T; Wong PS; Tan C; Sim E; Tan L; Goh PS; Wang SC; Khoo KL; Mukherjee A; Khoo SM; Chua G; Nilsson B; Lee KH; Tan P
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5980-7. PubMed ID: 14676123
[TBL] [Abstract][Full Text] [Related]
17. Individualized therapy in non-small-cell lung cancer: future versus current clinical practice.
Pérez-Soler R
Oncogene; 2009 Aug; 28 Suppl 1():S38-45. PubMed ID: 19680295
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis of lung cancer: molecular abnormalities and therapeutic implications.
Massion PP; Carbone DP
Respir Res; 2003; 4(1):12. PubMed ID: 14641911
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
20. Discovery of prostate cancer biomarkers by microarray gene expression profiling.
Sørensen KD; Ørntoft TF
Expert Rev Mol Diagn; 2010 Jan; 10(1):49-64. PubMed ID: 20014922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
